🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of SYD985 ...
Status
Completed
Location
Smilow Cancer Hospital (Yale)
Start Date
2020-05-28
Trial ID
NCT04205630
Treatments Being Tested
Purpose: This clinical trial is designed to evaluate the safety and effecti...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-01
Trial ID
NCT07126561
Treatments Being Tested
DEMETHER is a phase II trial exploring the maintenance of trastuzumab and p...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-07-22
Trial ID
NCT06172127
This study is designed to compare the anti-tumor activity as well as the sa...
Status
Active Not Recruiting
Location
UCLA Hematology Oncology
Start Date
2018-08-09
Trial ID
NCT03529110
Treatments Being Tested
The main objective of this study is to test the safety and effectiveness of...
Status
Completed
Location
City of Hope Medical Center
Start Date
2018-02-23
Trial ID
NCT03384940
Treatments Being Tested
The current study will compare PK, efficacy, safety, and immunogenicity of ...
Status
Completed
Location
Compassionate Cancer Care Medical Group, Inc.
Start Date
2014-09-23
Trial ID
NCT02187744
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-05-30
Trial ID
NCT05824975
This study is designed to compare the safety and efficacy of JSKN003 versus...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-02-18
Trial ID
NCT06846437
Treatments Being Tested
The primary objective of this study was to demonstrate pharmacokinetic simi...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT02594761
Treatments Being Tested
The purpose of this study is to provide post-trial access to alpelisib and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-01
Trial ID
NCT07679269
Treatments Being Tested